OGN.NYSEOrganon & CO

Form 4: Organon & Co. CFO Matthew Walsh Reports Stock Transactions

Sentiment:

SEC Form 4 Filing

📋All filings for Organon & CO
🔒Login to Follow

Chief Financial Officer Matthew Walsh reports transactions involving Organon & Co. common stock and restricted stock units.

Summary

  • On March 31, 2024, Matthew Walsh, the CFO of Organon & Co., reported transactions involving the company's common stock and restricted stock units (RSUs).
  • Walsh acquired 7,753 shares of common stock through the conversion of restricted stock units.
  • He also acquired 12,046 shares of common stock through the conversion of restricted stock units.
  • Additionally, Walsh disposed of 3,819 shares of common stock at a price of $18.8.
  • He also disposed of 5,933 shares of common stock at a price of $18.8.
  • Following these transactions, Walsh directly owns 84,109 shares of Organon & Co. common stock and 24,093 restricted stock units.

Sentiment

Score: 5

Explanation: This is a routine disclosure of insider transactions. The sentiment is neutral as it simply reports the facts of the transactions.

Future Outlook

The remaining restricted stock units are scheduled to vest on March 31, 2025, and March 31, 2026.

Industry Context

Form 4 filings are standard practice for reporting insider transactions and provide transparency to investors regarding the buying and selling activities of company executives.

Stakeholder Impact

  • The transactions may provide insights to stakeholders regarding management's perspective on the company's stock value.
  • The vesting schedule of RSUs incentivizes the executive to remain with the company.

Key Dates

DateDescription
03/31/2023One-third of the initially granted RSUs vested.
03/31/2024Date of the reported transactions, including vesting of RSUs and sale of common stock.
03/31/2025Remaining RSUs from the first grant to vest.
03/31/2025One-half of the remaining RSUs from the second grant to vest.
03/31/2026Remaining RSUs from the second grant to vest.
04/03/2024Date of the form filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.